These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2009135)

  • 1. Evidence for autocrine/paracrine growth stimulation by transforming growth factor-alpha during the process of skin tumor promotion.
    Imamoto A; Beltrán LM; DiGiovanni J
    Mol Carcinog; 1991; 4(1):52-60. PubMed ID: 2009135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential mechanism for the inhibition of epidermal growth factor binding to its receptor on mouse keratinocytes by anthrones and phorbol esters.
    Imamoto A; Beltrán LM; DiGiovanni J
    Carcinogenesis; 1990 Sep; 11(9):1543-9. PubMed ID: 2401043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of transforming growth factor-alpha mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis.
    Kiguchi K; Beltrán LM; You J; Rho O; DiGiovanni J
    Mol Carcinog; 1995 Apr; 12(4):225-35. PubMed ID: 7727044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the ability of 12-O-tetradecanoylphorbol-13-acetate to induce epidermal hyperplasia, transforming growth factor-alpha, and skin tumor promotion in wa-1 mice.
    Kiguchi K; Beltrán L; Dubowski A; DiGiovanni J
    J Invest Dermatol; 1997 May; 108(5):784-91. PubMed ID: 9129233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic alterations produced by chrysarobin (1,8-dihydroxy-3-methyl-9-anthrone) in SENCAR mouse skin: relationship to skin tumor promoting activity.
    Kruszewski FH; Naito M; Naito Y; DiGiovanni J
    J Invest Dermatol; 1989 Jan; 92(1):64-71. PubMed ID: 2462598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of chrysarobin skin tumor promotion.
    DiGiovanni J; Kruszewski FH; Chenicek KJ
    Carcinogenesis; 1988 Aug; 9(8):1445-50. PubMed ID: 3135955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of epidermal akt by diverse mouse skin tumor promoters.
    Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
    Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in epidermal polyamine levels and DNA synthesis following topical treatment with chrysarobin in SENCAR mice.
    Kruszewski FH; DiGiovanni J
    Cancer Res; 1988 Nov; 48(22):6390-5. PubMed ID: 3180057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of mouse epidermal protein kinase C isozyme activities following treatment with phorbol ester and non-phorbol ester tumor promoters.
    Wang XJ; Warren BS; Rupp T; Beltrán LM; DiGiovanni J
    Carcinogenesis; 1994 Dec; 15(12):2795-803. PubMed ID: 8001237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
    Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
    Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
    Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J
    Cancer Res; 2004 Apr; 64(7):2382-9. PubMed ID: 15059889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of epidermal growth factor binding to cultured mouse epidermal cells by tumor promoters.
    Murray AW; Froscio M
    Carcinogenesis; 1980 Aug; 1(8):681-4. PubMed ID: 11272121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor promoting activity of 1,8-dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice.
    DiGiovanni J; Boutwell RK
    Carcinogenesis; 1983; 4(3):281-4. PubMed ID: 6831635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of mouse skin tumor promotion by chrysarobin.
    DiGiovanni J; Decina PC; Prichett WP; Cantor J; Aalfs KK; Coombs MM
    Cancer Res; 1985 Jun; 45(6):2584-9. PubMed ID: 3986797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational augmentation of pro-matrix metalloproteinase 3 (prostromelysin 1) and a tissue inhibitor of metalloproteinases (TIMP)-1 mRNAs by epidermal growth factor and transforming growth factor alpha, but not by interleukin 1 alpha or 12-O-tetradecanoylphorbol 13-acetate in human uterine cervical fibroblasts: the possible involvement of an atypical protein kinase C.
    Hosono T; Ito A; Sato T; Nagase H; Mori Y
    Biol Pharm Bull; 1996 Oct; 19(10):1285-90. PubMed ID: 8913498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
    Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
    Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
    Kruszewski FH; Conti CJ; DiGiovanni J
    Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of application frequency on epidermal ornithine decarboxylase induction by chrysarobin in SENCAR mice.
    Kruszewski FH; Chenicek KJ; Digiovanni J
    Cancer Lett; 1986 Sep; 32(3):263-9. PubMed ID: 3768852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic mice.
    Wilker E; Bol D; Kiguchi K; Rupp T; Beltrán L; DiGiovanni J
    Mol Carcinog; 1999 Jun; 25(2):122-31. PubMed ID: 10365914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial characterization of epidermal protein kinase C in mice sensitive or resistant to phorbol ester.
    Hirabayashi N; Warren BS; Wang XJ; Petersen-Marht S; Beltran L; Davis MM; Ashendel CL; DiGiovanni J
    Mol Carcinog; 1990; 3(3):171-80. PubMed ID: 2372371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.